Renaissance Technologies’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-42,700
| Closed | -$53K | – | 4724 |
|
|
2022
Q1 | $53K | Buy |
42,700
+15,200
| +55% | +$18.9K | ﹤0.01% | 3905 |
|
|
2021
Q4 | $32K | Buy |
+27,500
| New | +$32K | ﹤0.01% | 3820 |
|
|
2021
Q2 | – | Sell |
-25,659
| Closed | -$70K | – | 3947 |
|
|
2021
Q1 | $70K | Sell |
25,659
-370,104
| -94% | -$1.01M | ﹤0.01% | 3238 |
|
|
2020
Q4 | $958K | Buy |
395,763
+185,069
| +88% | +$448K | ﹤0.01% | 2518 |
|
|
2020
Q3 | $482K | Buy |
210,694
+95,323
| +83% | +$218K | ﹤0.01% | 2822 |
|
|
2020
Q2 | $265K | Sell |
115,371
-37,925
| -25% | -$87.1K | ﹤0.01% | 3085 |
|
|
2020
Q1 | $264K | Sell |
153,296
-126,215
| -45% | -$217K | ﹤0.01% | 3019 |
|
|
2019
Q4 | $579K | Buy |
279,511
+76,149
| +37% | +$158K | ﹤0.01% | 2847 |
|
|
2019
Q3 | $590K | Buy |
203,362
+36,975
| +22% | +$107K | ﹤0.01% | 2809 |
|
|
2019
Q2 | $652K | Buy |
166,387
+113,105
| +212% | +$443K | ﹤0.01% | 2892 |
|
|
2019
Q1 | $251K | Buy |
53,282
+26,712
| +101% | +$126K | ﹤0.01% | 3147 |
|
|
2018
Q4 | $61K | Buy |
26,570
+1,724
| +7% | +$3.96K | ﹤0.01% | 3276 |
|
|
2018
Q3 | $155K | Buy |
24,846
+10,325
| +71% | +$64.4K | ﹤0.01% | 3194 |
|
|
2018
Q2 | $99K | Sell |
14,521
-30,500
| -68% | -$208K | ﹤0.01% | 3149 |
|
|
2018
Q1 | $378K | Buy |
+45,021
| New | +$378K | ﹤0.01% | 2991 |
|
|
2015
Q4 | – | Sell |
-1,500
| Closed | -$82K | – | 3520 |
|
|
2015
Q3 | $82K | Sell |
1,500
-3,163
| -68% | -$173K | ﹤0.01% | 3036 |
|
|
2015
Q2 | $512K | Buy |
4,663
+3,350
| +255% | +$368K | ﹤0.01% | 2715 |
|
|
2015
Q1 | $125K | Buy |
+1,313
| New | +$125K | ﹤0.01% | 2980 |
|